Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis. (2024). Swiss Medical Weekly, 154(7), 3695. https://doi.org/10.57187/s.3695